Biopharmaceutical Company

Source: www.topix.com --- 6 days ago
The lawsuits were brought by former Cephalon employees and filed under the qui tam provisions of the False Claims Act. ...

Source: www.reuters.com --- 33 days ago
(Reuters) - Biopharmaceutical Company Novacea Inc said it agreed to be acquired by privately held Transcept Pharmaceuticals Inc in an all-stock deal, under which Transcept stockholders will own 60 percent of the combined Company. ...

Source: www.businesswire.com --- 32 days ago
LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a Biopharmaceutical Company focused on discovering and developing novel therapeutics through the use of its ...

Source: www.marketwire.com --- 32 days ago
WINNIPEG, MANITOBA (MARKET WIRE) Medicure Inc. (TSX: MPH), a cardiovascular focused, Biopharmaceutical Company, today announced that new data presented at the annual European Society of Cardiology Congress in Munich, Germany showed AGGRASTAT(R) (tirofiban HCL) significantly lowers the incidence of heart attack after elective coronary angioplasty in coronary artery disease patients who have shown poor response to standard oral antiplatelet agents, aspirin and clopidogrel. The data comes from a double-blinded study of AGGRASTAT(R) entitled the 3T/2R Study (Tailoring Treatment with Tirofiban in patients showing Resistance to ...

Source: www.businesswire.com --- 33 days ago
MELBOURNE, Australia--(BUSINESS WIRE)--Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian Biopharmaceutical Company specializing in oral immunotherapy using naturally derived antibodies and ...

Source: www.businesswire.com --- 21 days ago
LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a Biopharmaceutical Company engaged in the development and commercialization of therapeutics based on molecular ...

Source: www.medicalnewstoday.com --- 32 days ago
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL), a Biopharmaceutical Company engaged in the discovery and development of novel therapeutics to treat Central Nervous System (CNS) diseases and cancer, announced the successful completion of preclinical studies (in-vitro and in-vivo in mice) on ANAVEX 2-73, a novel sigma-1 receptor agonist for the treatment of Alzheimer's disease. ...

Source: www.medicalnewstoday.com --- 2 days ago
Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a Biopharmaceutical Company focused on the treatment of obesity and other central nervous system-related disorders, announced the initiation of its first clinical trial with OREX-003, a proprietary sustained release formulation of zonisamide plus olanzapine. ...

Source: www.medicalnewstoday.com --- 31 days ago
Fibrex Medical, a Biopharmaceutical Company focusing on cardiovascular and inflammatory diseases, announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart muscle that results from remedial treatment following a heart attack. The results will be presented at the ESC Congress today in Munich, Germany. The Phase II clinical trial of FX06 (F.I.R.E. ...

Source: www.medicalnewstoday.com --- 30 days ago
QuatRx Pharmaceuticals, a privately-held Biopharmaceutical Company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, announced that it has initiated a second Phase 3 clinical trial of Ophena(TM) (ospemifene tablets), the Company's estrogen-free oral therapy in development for the treatment of vaginal symptoms associated with menopause. ...

Source: www.medicalnewstoday.com --- 3 days ago
Alimera Sciences, Inc., a privately held Biopharmaceutical Company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, reported the interim month six safety and efficacy results from the first human pharmacokinetic (PK) study of Iluvien(TM). Iluvien is an intravitreal insert being developed for the treatment of diabetic macular edema (DME). ...

Source: www.moreover.com --- 32 days ago
mpleted Lumavita AG, a start-up specialty Biopharmaceutical Company focusing on anti-infectives for women?s health raised ?11 million in a first round funding led by Atlas Venture, BB Biotech Ventures, and BioMedInvest. The Company also announced the ...

Source: www.earthtimes.org --- 32 days ago
ALACHUA, Fla. - Nanotherapeutics, a privately held specialty Biopharmaceutical Company, announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX™ Hydrogel, a to ...

Source: www.kansas.com --- 30 days ago
Weiqiang Zhang has been hired by Ventria Bioscience to manage its plant breeding and nursery operations in Junction City, the Company announced today. He will work to increase protein yields and adapt plant varieties to local production areas. Zhang was a research scientist at Kansas State from 2000-01 and received his doctorate in agronomy from Louisiana State in 2005. Ventria is based in Fort Collins, Colo., and is in the Biopharmaceutical industry. ...

Source: pharmalicensing.com --- 3 days ago
You will join an established Biopharmaceutical Company, dedicated to the discovery and development of innovative new treatments for severe diseases. CNS will be a major growth area, with significant investment and expansion scheduled for the next 3 years. The Company will build upon its existing expertise and strong product portfolio in neurological conditions to further strengthen its position as a recognised specialist in this field.As Director, CNS Pharmacology you will provide high-quality technical, scientific and professional leadership to a team of staff, championing and implementing innovative science within the Pain & Migraine therapy area. This expert group specialises in the development and interpretation of in vivo disease models, but works closely with in vitro CNS Biology to elucidate drug targets and understand disease mechanisms and with Clinical Pharmacology to identify predictive biomarkers and surrogate markers. In this high profile role, you will help to define the research strategy for these therapeutic areas, building upon existing expertise and driving breakthrough research into new targets and mechanisms. As Pre-Project Champion and/or Project Leader, you will liaise closely with colleagues across the business, operating collectively to progress multi-disciplinary CNS research endeavours.You will be qualified to PhD level in Pharmacology, Neuroscience or a closely related discipline, with considerable exper ...

Source: pharmalicensing.com --- 3 days ago
We seek a Quality and Compliance Manager for Pharmacovigilance for our client, a Global Biopharmaceutical Company. Reporting to the Medical Director, this key role is to maintain and drive aspects of quality and compliance by working with and adapting current established procedures and initiate new ones where identified.The role may be expanded after a satisfactory initial period of training and review to the function of Responsible Person for UK and Ireland. The broad areas of focus and delivery are Pharmacovigilance, Distribution, ABPI Compliance, 3rd Party Contracts, SOPs and Archiving.You will have experience and a good understanding of adverse event reporting and Pharmacovigilance processes, and preferably also the ABPI Code of Practice and regulations. You will have recent practical experience in handling, storage and distribution, transactions in selling, or procuring medicinal products, and managerial experience in controlling and directing the wholesale distribution of medicinal products. You will hold a life sciences degree.To apply, please contact Tim Wagstaff at RSA Pharmarecruit on 01707 280814 or email CV's to Tim.Wagstaff@theRSAgroup.com. Please note that only candidates with EU work authorisation will be considered. ...

Source: pharmalicensing.com --- 5 days ago
Our client is a Biopharmaceutical R&D group focusing on antibody and recombinant proteins. They currently have an opportunity for a Process Science Manager:To develop and transfer validatable analytical methodologies to Production and/or Quality ControlTo develop new and existing technologies for the commercial manufacture and quality control of new and existing productsTo perform project work as requested by, and as defined by objectives set by the departmental directorTo develop novel methodologies to support new and existing manufacturing processes, apply mathematical and statistical modelling to validate scaled down process models and define process limitsTo transfer new small scale methodologies and techniques to production scale and resolve technical issues that may ariseTo develop novel analytical techniques and transfer these to Quality Control as a validatable package, undertake binding and kinetic studies for new and existing products to support preclinical studies as requiredTo act as the primary scientific interface between the Company and third parties for technical discussions surrounding the development of new process and analytical techniquesTo write the relevant sections of regulatory documents (e.g. IND, CTD etc) for European, US and worldwide submissionTo manage the relevant staff within the Process Science group in terms of objective setting, personnel and activities and be responsible for budgetary (including ...

Source: pharmalicensing.com --- 5 days ago
Our client, a Global Biopharmaceutical Company, is looking for a Quality and Compliance Manager. Reporting to the Medical Director, this key role is to maintain and drive aspects of quality and compliance by working with and adapting current established procedures and initiate new ones where identified.The role may be expanded after a satisfactory initial period of training and review to the function of Responsible Person for UK and Ireland. The broad areas of focus and delivery are Pharmacovigilance, Distribution, ABPI Compliance, 3rd Party Contracts, SOPs and Archiving.RequirementsYou will have experience and a good understanding of adverse event reporting and Pharmacovigilance processes, and preferably also the ABPI Code of Practice and regulationsYou will have recent practical experience in handling, storage and distribution, transactions in selling, or procuring medicinal products, and managerial experience in controlling and directing the wholesale distribution of medicinal productsYou will hold a life sciences degree.To apply, please contact Tim Wagstaff at RSA Pharmarecruit on 01707 280814 or email CV's to Tim.Wagstaff@theRSAgroup.com. Please note that only candidates with EU work authorisation will be considered. ...

Source: digital50.com --- 4 days ago
ALAMEDA, Calif.-(Business Wire)-October 1, 2008 - Arriva Pharmaceuticals, a Biopharmaceutical Company focused on developing anti-inflammatory therapies, announced today that it had been granted a patent in the U.S. for methods to produce certain proteins in yeast. Among the proteins whose... ...

Source: www.primenewswire.com --- 5 days ago
WALTHAM, Mass., Oct. 1, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, Biopharmaceutical Company developing novel therapeutics to treat cancer and eye diseases, has entered into a strategic collaboration with Symphony Capital Partners, L.P. (Symphony) that will provide OXiGENE with up to $40 million to further advance its pipeline of vascular disrupting agent (VDA) drug candidates for cancer and eye disease. ...